Tandem Diabetes Care, Inc. (TNDM)
19.90
-0.53
(-2.59%)
USD |
NASDAQ |
Sep 04, 16:00
19.95
+0.05
(+0.25%)
After-Hours: 20:00
Tandem Diabetes Care SG&A Expense (TTM) : 441.37M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 441.37M |
| March 31, 2026 | 439.32M |
| December 31, 2025 | 444.99M |
| September 30, 2025 | 437.73M |
| June 30, 2025 | 428.92M |
| March 31, 2025 | 413.57M |
| December 31, 2024 | 389.82M |
| September 30, 2024 | 369.74M |
| June 30, 2024 | 349.43M |
| March 31, 2024 | 352.80M |
| December 31, 2023 | 352.50M |
| September 30, 2023 | 364.44M |
| June 30, 2023 | 369.22M |
| March 31, 2023 | 352.22M |
| December 31, 2022 | 335.68M |
| September 30, 2022 | 309.49M |
| June 30, 2022 | 290.31M |
| March 31, 2022 | 276.22M |
| December 31, 2021 | 261.51M |
| September 30, 2021 | 244.53M |
| June 30, 2021 | 229.83M |
| March 31, 2021 | 213.75M |
| December 31, 2020 | 204.90M |
| September 30, 2020 | 195.95M |
| June 30, 2020 | 190.37M |
| Date | Value |
|---|---|
| March 31, 2020 | 180.49M |
| December 31, 2019 | 165.74M |
| September 30, 2019 | 152.35M |
| June 30, 2019 | 137.21M |
| March 31, 2019 | 119.27M |
| December 31, 2018 | 105.23M |
| September 30, 2018 | 94.35M |
| June 30, 2018 | 84.97M |
| March 31, 2018 | 84.44M |
| December 31, 2017 | 86.38M |
| September 30, 2017 | 84.14M |
| June 30, 2017 | 84.70M |
| March 31, 2017 | 83.69M |
| December 31, 2016 | 82.83M |
| September 30, 2016 | 63.77M |
| June 30, 2016 | 62.21M |
| March 31, 2016 | 60.72M |
| December 31, 2015 | 58.08M |
| September 30, 2015 | 78.19M |
| June 30, 2015 | 77.97M |
| March 31, 2015 | 76.44M |
| December 31, 2014 | 75.12M |
| September 30, 2014 | 69.31M |
| June 30, 2014 | 62.42M |
| March 31, 2014 | 55.68M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Modular Medical, Inc. | 8.084M |
| Senseonics Holdings, Inc. | 98.17M |
| NeuroPace, Inc. | 66.09M |
| Abbott Laboratories | 13.94B |
| Accuray, Inc. | 86.17M |